Monoclonal antibodies represent the largest and fastest-growing segment of international biopharma. While these therapeutic agents are a boon for global healthcare, productivity constraints pose a serious challenge for manufacturers ...
Bio & Medicine
Aug 13, 2014
0
0
An experimental antivenom has been developed against dendrotoxins from the world's most feared venomous snake, the black mamba, which can be found in Africa. The experiments were carried out in collaboration between DTU and ...
Biotechnology
Oct 2, 2018
1
173
Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.
Biotechnology
Jan 15, 2013
5
0
Swiss scientists have succeeded in clearing a toxin from blood in just a few minutes, using specially produced nanomagnets. The procedure appears promising. If the method can be put into practice, it could one day help people ...
Bio & Medicine
Aug 25, 2010
0
0
As the SARS-CoV-2 virus that causes COVID-19 continues to evolve, immunologists and infectious diseases experts are eager to know whether new variants are resistant to the human antibodies that recognized initial versions ...
Cell & Microbiology
Jul 23, 2021
1
595
As the COVID-19 curve shows signs of flattening in the U.S. and elsewhere, public health officials are trying to grasp just how many people have been infected. Now, a proof-of-concept study in ACS' Analytical Chemistry describes ...
Analytical Chemistry
Apr 29, 2020
4
709
Bioengineers and life scientists incorporate hybridoma technology to produce large numbers of identical antibodies, and develop new antibody therapeutics and diagnostics. Recent preclinical and clinical studies on the technology ...
Scientists have created a high-speed method to generate thousands of different, small, stable proteins from scratch that can be custom-designed to bind to specific therapeutic targets.
Biochemistry
Sep 27, 2017
0
331
Scientists investigating how the human immune system defends against malaria have uncovered a rare phenomenon: antibodies working together to bind to a vulnerable spot on the parasite.
Biochemistry
Oct 23, 2018
0
419
Chemists at the California Institute of Technology (Caltech) and The Scripps Research Institute (SRI) have developed an innovative technique to create cheap but highly stable chemicals that have the potential to take the ...
Bio & Medicine
Aug 28, 2009
2
0
